Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Board Meeting will be held on 13th ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Ltd has informed BSE that its Board of Directors will meet on Thursday, 13 November 2025 at 5 PM at its Chennai corporate office. The main agenda is to consider and approve the unaudited financial results for the quarter ended 30 September 2025, as required under SEBI's Listing Regulations. The meeting also has a standard provision to discuss any other matter with the Chairman's permission. The trading window for promoters, directors, designated employees, and connected persons has been closed and will reopen 48 hours after the results are announced.
Routine regulatory intimation with no business or financial impact. Investors should watch for the Q2 FY26 results announcement following the meeting, which could influence short-term stock movement.